Improved Diagnostics Help to Identify Clinical Features and Biomarkers That Predict Mycoplasma pneumoniae Community-acquired Pneumonia in Children.

导出 OA

翻译打印收藏纠错

作者： Patrick M,Meyer Sauteur ^[1] ; Selina,Krautter ^[1] ; Lilliam,Ambroggio ^[2] ; Michelle,Seiler ^[3] ; Paolo,Paioni ^[1] ; Christa,Relly ^[1] ; Riccarda,Capaul ^[4] ; Christian,Kellenberger ^[5] ; Thorsten,Haas ^[6] ; Claudine,Gysin ^[7] ; Lucas M,Bachmann ^[8] ; Annemarie M C,van Rossum ^[9] ; Christoph,Berger ^[1]

作者单位： Division of Infectious Diseases and Hospital Epidemiology, University Children's Hospital Zurich, Zurich, Switzerland. ^[1] Emergency Medicine and Hospital Medicine, Children's Hospital Colorado, Denver, Colorado, USA. ^[2] Emergency Department, University Children's Hospital Zurich, Zurich, Switzerland. ^[3] Institute of Medical Virology, University of Zurich, Zurich, Switzerland. ^[4] Division of Diagnostic Imaging, University Children's Hospital Zurich, Zurich, Switzerland. ^[5] Division of Anesthesiology, University Children's Hospital Zurich, Zurich, Switzerland. ^[6] Division of Otolaryngology, University Children's Hospital Zurich, Zurich, Switzerland. ^[7] Medignition Inc Research Consultants, Zurich, Switzerland. ^[8] Department of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Erasmus MC University Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands. ^[9]

关键词 C-reactive protein antibiotics diagnosis procalcitonin treatment